GLP-1s
ATN Week in Review: Fitness & Pharma Are Growing Closer
Pvolve's recent partnership with Weight Watchers is highly important for the fitness industry amid the rise of GLP-1s.
Weight Watchers Adds Pvolve Fitness Classes in GLP-1 Support Play
Weight Watchers is the latest telehealth company to bundle pharma and fitness, a model that's quickly becoming the industry standard.
Super Bowl Advertisers Are Playing Offense on Wellness
This year's Super Bowl LX ad slate shows just how much has changed in the conversation around health and wellness.
For GLP-1 Users, Effort Could Be the Key Factor in Long-Term Health
New data from Noom suggests that people who put more effort into eating healthy and working out see the best results from weight-loss drugs.
Move Over, Protein? Why 2026 Is Shaping Up to Be the Year of Fiber
From functional beverages to GLP-1 nutrition strategies, experts say fiber is poised to overtake (or at least equal) protein in popular importance.
New Study Reveals an Inconvenient Truth About Weight-Loss Drugs
GLP-1s deliver dramatic weight loss, but a new study reveals what happens when treatment stops and why weight often comes back fast.
These Nutrition Trends Will Rise & Fall in 2026, Experts Predict
Experts from at-home testing and nutrition company Zoe shared where they see industry trends going, for better or worse, in 2026.
The New Weight-Loss Problem Isn’t Access. It’s Burnout, Survey Finds
Weight loss is a top priority for Americans amid the rise of GLP-1s, but rising emotional strain suggests the system is starting to crack
Weight Watchers Goes All-In on GLP-1s With App Overhaul
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
